vs
Side-by-side financial comparison of DaVita (DVA) and Masco (MAS). Click either name above to swap in a different company.
DaVita is the larger business by last-quarter revenue ($3.6B vs $1.9B, roughly 1.9× Masco). Masco runs the higher net margin — 11.9% vs 6.5%, a 5.4% gap on every dollar of revenue. On growth, DaVita posted the faster year-over-year revenue change (12.3% vs 6.5%). Over the past eight quarters, DaVita's revenue compounded faster (6.6% CAGR vs -4.2%).
DaVita Inc. is an American company that provides kidney dialysis services through a network of 2,675 outpatient centers in the United States, serving 200,800 patients, and 367 outpatient centers in 11 other countries serving 49,400 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation.
Masco Corporation is an American manufacturer of products for the home improvement and new home construction markets. Comprising more than 20 companies, the Masco conglomerate operates nearly 60 manufacturing facilities in the United States and over 20 in other parts of the world. Since 1969 it trades on the NYSE. Under the leadership of Richard Manoogian, the company grew exponentially and subsequently joined the Fortune 500 list of largest U.S. corporations.
DVA vs MAS — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $3.6B | $1.9B |
| Net Profit | $234.2M | $228.0M |
| Gross Margin | — | 35.8% |
| Operating Margin | 15.5% | 16.5% |
| Net Margin | 6.5% | 11.9% |
| Revenue YoY | 12.3% | 6.5% |
| Net Profit YoY | 43.8% | 14.5% |
| EPS (diluted) | $3.22 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $3.6B | $1.9B | ||
| Q4 25 | $3.6B | $1.8B | ||
| Q3 25 | $3.4B | $1.9B | ||
| Q2 25 | $3.4B | $2.1B | ||
| Q1 25 | $3.2B | $1.8B | ||
| Q4 24 | $3.3B | $1.8B | ||
| Q3 24 | $3.3B | $2.0B | ||
| Q2 24 | $3.2B | $2.1B |
| Q1 26 | $234.2M | $228.0M | ||
| Q4 25 | $234.2M | $165.0M | ||
| Q3 25 | $150.3M | $189.0M | ||
| Q2 25 | $199.3M | $270.0M | ||
| Q1 25 | $162.9M | $186.0M | ||
| Q4 24 | $259.3M | $182.0M | ||
| Q3 24 | $214.7M | $167.0M | ||
| Q2 24 | $222.7M | $258.0M |
| Q1 26 | — | 35.8% | ||
| Q4 25 | — | 33.9% | ||
| Q3 25 | — | 34.2% | ||
| Q2 25 | — | 37.6% | ||
| Q1 25 | — | 35.8% | ||
| Q4 24 | — | 34.8% | ||
| Q3 24 | — | 36.6% | ||
| Q2 24 | — | 37.5% |
| Q1 26 | 15.5% | 16.5% | ||
| Q4 25 | 15.5% | 13.8% | ||
| Q3 25 | 14.8% | 15.8% | ||
| Q2 25 | 15.9% | 20.1% | ||
| Q1 25 | 13.6% | 15.9% | ||
| Q4 24 | 17.2% | 15.9% | ||
| Q3 24 | 16.4% | 18.0% | ||
| Q2 24 | 15.9% | 19.0% |
| Q1 26 | 6.5% | 11.9% | ||
| Q4 25 | 6.5% | 9.2% | ||
| Q3 25 | 4.4% | 9.9% | ||
| Q2 25 | 5.9% | 13.2% | ||
| Q1 25 | 5.1% | 10.3% | ||
| Q4 24 | 7.9% | 10.0% | ||
| Q3 24 | 6.6% | 8.4% | ||
| Q2 24 | 7.0% | 12.3% |
| Q1 26 | $3.22 | — | ||
| Q4 25 | $3.22 | $0.81 | ||
| Q3 25 | $2.04 | $0.90 | ||
| Q2 25 | $2.58 | $1.28 | ||
| Q1 25 | $2.00 | $0.87 | ||
| Q4 24 | $3.08 | $0.85 | ||
| Q3 24 | $2.50 | $0.77 | ||
| Q2 24 | $2.50 | $1.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $700.7M | — |
| Total DebtLower is stronger | $10.2B | $2.9B |
| Stockholders' EquityBook value | $-651.1M | $27.0M |
| Total Assets | $17.5B | $5.2B |
| Debt / EquityLower = less leverage | — | 109.07× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $700.7M | — | ||
| Q4 25 | $700.7M | $647.0M | ||
| Q3 25 | $736.5M | $559.0M | ||
| Q2 25 | $739.4M | $390.0M | ||
| Q1 25 | $511.9M | $377.0M | ||
| Q4 24 | $846.0M | $634.0M | ||
| Q3 24 | $1.1B | $646.0M | ||
| Q2 24 | $437.2M | $398.0M |
| Q1 26 | $10.2B | $2.9B | ||
| Q4 25 | $10.2B | $2.9B | ||
| Q3 25 | $10.2B | — | ||
| Q2 25 | $10.1B | — | ||
| Q1 25 | $9.6B | — | ||
| Q4 24 | $9.2B | $2.9B | ||
| Q3 24 | $9.3B | — | ||
| Q2 24 | $8.5B | — |
| Q1 26 | $-651.1M | $27.0M | ||
| Q4 25 | $-651.1M | $-185.0M | ||
| Q3 25 | $-571.9M | $-78.0M | ||
| Q2 25 | $-369.6M | $-84.0M | ||
| Q1 25 | $-267.1M | $-254.0M | ||
| Q4 24 | $121.1M | $-279.0M | ||
| Q3 24 | $386.7M | $-88.0M | ||
| Q2 24 | $632.9M | $-26.0M |
| Q1 26 | $17.5B | $5.2B | ||
| Q4 25 | $17.5B | $5.2B | ||
| Q3 25 | $17.6B | $5.3B | ||
| Q2 25 | $17.5B | $5.3B | ||
| Q1 25 | $17.1B | $5.1B | ||
| Q4 24 | $17.3B | $5.0B | ||
| Q3 24 | $17.5B | $5.3B | ||
| Q2 24 | $17.0B | $5.4B |
| Q1 26 | — | 109.07× | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 75.76× | — | ||
| Q3 24 | 23.95× | — | ||
| Q2 24 | 13.35× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
